<p>|Recommendation/statement|PICO question informing recommendation and discussion|Level of evidence|
|---|---|---|
|Remission induction for active, severe disease| | |
|Ungraded position statement: For patients with active, severe EGPA, either IV pulse GCs or high-dose oral GCs may be prescribed as initial therapy.|3|Very low|
|Ungraded position statement: For patients with active, severe EGPA, either cyclophosphamide or rituximab may be prescribed for remission induction.|4|Very low|